High Prevalence of C-Reactive Protein Elevation with Normal Triglycerides (100–149 mg/dL): Are Triglyceride Levels Below 100 mg/dL More Optimal in Coronary Heart Disease Risk Assessment?

作者: Irfan Ahmad , Min Zhan , Michael Miller

DOI: 10.1097/00000441-200504000-00002

关键词:

摘要: ABSTRACT Background The National Cholesterol Education Program defines a fasting triglyceride level below 150 mg/dL as normal. However, observational data suggest that levels above 100 mg/dL may predict coronary heart disease (CHD) events. Methods To determine the prevalence of systemic inflammation with normal (100–149 mg/dL), obtained from population-based cross-sectional study 4412 men and women in third Health Nutrition Examination Survey were reviewed. Measurements included lipids lipoproteins serum C-reactive protein (CRP) measured using Behring Nephelometer Analyzer System. Results High CRP was equally prevalent whether designated cutpoint greater than or equal to 100 (unadjusted OR, 2.0; 95% CI, 1.7-2.3) 150 1.9; 1.6-2.2). After adjustment for other covariates, range 149 mg/dL remained independently associated elevated (OR, 1.3; 1.02-1.67). In addition, an approximately fivefold higher likelihood observed between body mass index (BMI; 24–24.9) compared lower ( P Conclusions These indicate "normal" (100–150 mg/dL) are (eg,

参考文章(33)
Michael Miller, Alexander Seidler, Azita Moalemi, Thomas A Pearson, Normal Triglyceride Levels and Coronary Artery Disease Events: The Baltimore Coronary Observational Long-Term Study Journal of the American College of Cardiology. ,vol. 31, pp. 1252- 1257 ,(1998) , 10.1016/S0735-1097(98)00083-7
Lindsay J. Marshall, Lara S. P. Ramdin, Teresa Brooks, Peter Charlton DPhil, Janis K. Shute, Plasminogen Activator Inhibitor-1 Supports IL-8-Mediated Neutrophil Transendothelial Migration by Inhibition of the Constitutive Shedding of Endothelial IL-8/Heparan Sulfate/Syndecan-1 Complexes Journal of Immunology. ,vol. 171, pp. 2057- 2065 ,(2003) , 10.4049/JIMMUNOL.171.4.2057
Michael Miller, Barbara Cosgrove, Stephen Havas, Update on the role of triglycerides as a risk factor for coronary heart disease. Current Atherosclerosis Reports. ,vol. 4, pp. 414- 418 ,(2002) , 10.1007/S11883-002-0044-0
Daniel E. Ford, Thomas P. Erlinger, Depression and C-Reactive Protein in US Adults Archives of Internal Medicine. ,vol. 164, pp. 1010- 1014 ,(2004) , 10.1001/ARCHINTE.164.9.1010
Katherine Esposito, Alessandro Pontillo, Carmen Di Palo, Giovanni Giugliano, Mariangela Masella, Raffaele Marfella, Dario Giugliano, Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women JAMA. ,vol. 289, pp. 1799- 1804 ,(2003) , 10.1001/JAMA.289.14.1799
Lawrence J. Appel, Nonpharmacologic therapies that reduce blood pressure: A fresh perspective Clinical Cardiology. ,vol. 22, pp. 1- 5 ,(1999) , 10.1002/CLC.4960221502
M. Frohlich, A. Imhof, G. Berg, W. L. Hutchinson, M. B. Pepys, H. Boeing, R. Muche, H. Brenner, W. Koenig, Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. ,vol. 23, pp. 1835- 1839 ,(2000) , 10.2337/DIACARE.23.12.1835